LBA3 Compartmental radioimmunotherapy (cRIT) 131I-OMBURTAMAB in patients with neuroblastoma (NB) central nervous system (CNS) and/or leptomeningeal (LM) metastases: Updated results from pivotal Trial 101
| Autor: | Basu, E., Mora, J., Streby, K., Bear, M., Sano, H., Marachelian, A., Harrison, D., Nysom, K., Pandit-Taskar, N., Zanzonico, P., Fabricius, S., During, M., Nielsen, J.R., Kramer, K. |
|---|---|
| Zdroj: | In Immuno-Oncology and Technology December 2022 16 Supplement 1 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|